Skip to main content

Home/ Business News/ Group items tagged Astellas Pharmaceuticals

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Equities Group

Medivation Stock Doubles to Lead Prostate Cancer Biotechs | equities.com - 0 views

editorial.equities.com/...-lead-prostate-cancer-biotechs

equities.com investing Medivation prostate cancer cancer MDVN ALPMY Astellas Pharmaceuticals MDV3100 DNDN Dendreon Corp. JNJ healthcare stocks healthcare Anika Therapeutics ANIK ABIOMED ABMD SonoSite SONO SNT Senesco Technologies Hansen Medical HNSN DXCM

shared by Equities Group on 04 Nov 11 - No Cached
  • Equities Group on 04 Nov 11
     
    Stock in biotech company Medivation more than doubled in value after reports that their phase III study of a new drug to treat prostate cancer has showed major success.
bheru_kumar

Dermatology OTC Medications Market Benefit and Volume 2022 with Status and Prospect to ... - 0 views

reportsandinsights.com/...atology-otc-medications-market

Dermatology OTC Medications Market Research Report Share 2021 Size 2022 Trends Key Players Global Analysis Industry News Forecast CAGR USA

shared by bheru_kumar on 11 Oct 22 - No Cached
  • bheru_kumar on 11 Oct 22
     
    Reports and Insights issued a report recently titled "Dermatology OTC Medications Market: Opportunity Analysis and Future Assessment 2022-2030" which examines and assesses the market's status over the forecast period. It is a thorough investigation that focuses on elementary and secondary drivers, leading segments, market size and share, and geographical assessment. The study also provides a comprehensive evaluation at of the leading players, major partnerships and alliances, mergers, and acquisitions, along with the trending innovation and corporate strategies.
1 - 2 of 2
Showing 20▼ items per page